Boston Scientific Corp (BSX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Sales | 2,490,000 | 2,379,000 | 2,409,000 | 2,222,000 | 2,257,000 |
| Cost of Goods | 739,000 | 672,000 | 674,000 | 637,000 | 632,000 |
| Gross Profit | 1,751,000 | 1,707,000 | 1,735,000 | 1,585,000 | 1,625,000 |
| Operating Expenses | 1,360,000 | 1,299,000 | 1,416,000 | 1,208,000 | 1,400,000 |
| Operating Income | 392,000 | 407,000 | 319,000 | 377,000 | 225,000 |
| Interest Expense | 57,000 | 61,000 | 57,000 | 57,000 | 58,000 |
| Other Income | 12,000 | -23,000 | -34,000 | -11,000 | -76,000 |
| Pre-tax Income | 347,000 | 323,000 | 228,000 | 309,000 | 91,000 |
| Income Tax | -209,000 | 26,000 | 842,000 | 26,000 | -55,000 |
| Net Income Continuous | 556,000 | 297,000 | -614,000 | 283,000 | 146,000 |
| Net Income | $556,000 | $297,000 | $-614,000 | $283,000 | $146,000 |
| EPS Basic Total Ops | 0.40 | 0.22 | -0.45 | 0.21 | 0.11 |
| EPS Basic Continuous Ops | 0.40 | 0.22 | -0.45 | 0.21 | 0.11 |
| EPS Diluted Total Ops | 0.40 | 0.21 | -0.44 | 0.20 | 0.11 |
| EPS Diluted Continuous Ops | 0.40 | 0.21 | -0.44 | 0.20 | 0.11 |
| EBITDA(a) | $391,000 | $408,000 | $319,000 | $377,000 | $225,000 |